Resources

In this webinar, learn how best practices for targeting and engaging physicians both in-person and via non-personal promotion techniques.

In the immediate post-launch timeframe, pharma companies can use market access research to improve coverage and utilization. In this webinar, our experts explain the benefits of everything from post-label indication research to competitor analyses and

In this webinar, MMIT’s Steve Callahan and AssistRx’s Brok Vandersteen discuss the payer, regulatory and market updates that will impact patient services’ financial assistance programs in 2025.

In this webinar, learn what kinds of market access research pharma companies should complete in the six to twelve months before launch to strengthen their performance.

In this BioPharma Dive webinar, Dinesh Kabaleeswaran, SVP of Consulting and Advisory Services at MMIT, and Jen Klarer, partner and head of Cell & Gene Therapy at The Dedham Group, explain the results of our

This webinar details how and why manufacturers benefit from early market research, using client use cases to show how planning for potential access scenarios leads to greater utilization at launch.

To eliminate access barriers, manufacturers need more than the traditional coverage and restriction data. This webinar addresses how and why market access is broadening to include patient-level data and analytics.

In a recent BioPharma Dive webinar, three industry experts discussed how integrated RWD can help pharma companies understand and improve the patient treatment journey.

Whether new clinical results support your brand or a new competitor is challenging it, rapid turn-around market research can help enhance manufacturers’ understanding of key market events or unexpected changes in the market.

Learn how a product’s placement on pathways affects its utilization and uptake, and ultimately, patient’s access to life saving therapies.

Explore how we can expect the market to react and how factors such as launch timing, interchangeability, and contracting will shape the immunology landscape.

MMIT’s FormTrak tool helps prescribers get their patients on the right therapy even amid complex drug coverage requirements. FormTrak’s integration in Veeva CRM, pharma field teams can deliver an access message right in Veeva’s platform.

Understanding a large complex payer and their subsidiaries to segment your contracting plan or recognizing lives enrollment shifts in specific geographies, having payer data source solution to support your sales and marketing team is crucial.

Payer coverage policies continue to become more complex with increasing access hurdles. Dig into ways to sift through the noise and uncover payer account intervention and pull-through opportunities via dashboards and real-time alerts.

Learn how formularies are currently managed, examine some of the key challenges faced by payers and PBMs, and evaluate new integrated solutions to optimize management of both pharmacy and medically covered drugs.

Factors complicate the payer enrollment landscape, making it challenging to project membership rolls across payers, geographies and channels. See enrollment projections, the drivers behind them and what you can expect from the 2021 payer landscape.

Learn how claims reimbursement is currently being managed, as well as some best practices for leveraging specialty drug data to streamline the process.

Access barriers to the use of innovative technology such as administrative burden and reimbursement challenges. We will also touch upon payer concern about costs which might be underlying these issues.

Learn when and how to select the right analogs to set the most accurate expectations and payer strategy at launch.